Satya S S Sagi is the Founder and CEO of Techsol Life Sciences, where they lead the development of integrated clinical development and medical affairs solutions for the global biopharmaceutical and medical device sectors. With a background that includes roles at Siemens, Oracle, and iLabs, Sagi has extensive experience in life sciences software product development and clinical research services. At Techsol Life Sciences, they focus on delivering regulatory compliant solutions and innovative technology that accelerates the market entry of novel treatments. Additionally, Sagi is set to assume the role of CEO at SciMax Global in 2024.
This person is not in any teams